Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials.
Eisuke BookaChiyo K ImamuraMasashi TakeuchiHirofumi KawakuboHiroya TakeuchiYusuke TanigawaraYuko KitagawaNarikazu BokuPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2022)
It is suggested that the refined S-1 dosage formula can recommend optimal dose in terms of safety and efficacy.